Evan Seigerman
Stock Analyst at BMO Capital
(1.44)
# 1733
Out of 5,372 analysts
160
Total ratings
45.24%
Success rate
11.26%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IRON Disc Medicine | Maintains: Outperform | 112 120 | 50.91 | 135.71% | 6 | May 12, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Market Perform | 96 115 | 124.03 | -7.28% | 15 | May 6, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 115 120 | 108.88 | 10.21% | 16 | Apr 17, 2025 | |
BIIB Biogen | Maintains: Market Perform | 156 139 | 129.45 | 7.38% | 18 | Feb 13, 2025 | |
VRTX Vertex Pharmaceutica... | Maintains: Outperform | 520 545 | 448.12 | 21.62% | 15 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 57 61 | 47.8 | 27.62% | 11 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 48 52 | 69.88 | -25.59% | 12 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1001 1101 | 797.45 | 38.07% | 8 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 20.9 | 91.39% | 1 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 110 59 | n/a | n/a | 8 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 40 | 9.91 | 303.63% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 757 788 | 520.56 | 51.38% | 15 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 8 3 | 1.78 | 40.45% | 2 | Aug 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 263 243 | 294.75 | -17.56% | 6 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 5.16 | 132.56% | 2 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 60 | 24.2 | 147.93% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 27 | 1.4 | 1828.57% | 2 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 7 | n/a | n/a | 4 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 9 15 | n/a | n/a | 4 | Dec 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 35 | n/a | n/a | 4 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 14 17 | n/a | n/a | 6 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 30 | 1.48 | 1927.03% | 3 | May 12, 2020 |